- Home
- TGL vs PHIO Comparison
TGL vs PHIO Comparison
Compare TGL & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGL
- PHIO
- Stock Information
- Founded
- TGL 2020
- PHIO 2011
- Country
- TGL United States
- PHIO United States
- Employees
- TGL N/A
- PHIO N/A
- Industry
- TGL Retail: Computer Software & Peripheral Equipment
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- TGL Technology
- PHIO Health Care
- Exchange
- TGL Nasdaq
- PHIO Nasdaq
- Market Cap
- TGL 7.3M
- PHIO 8.0M
- IPO Year
- TGL 2022
- PHIO N/A
- Fundamental
- Price
- TGL $0.16
- PHIO $1.67
- Analyst Decision
- TGL
- PHIO Strong Buy
- Analyst Count
- TGL 0
- PHIO 1
- Target Price
- TGL N/A
- PHIO $36.00
- AVG Volume (30 Days)
- TGL 7.1M
- PHIO 981.0K
- Earning Date
- TGL 02-14-2025
- PHIO 04-01-2025
- Dividend Yield
- TGL N/A
- PHIO N/A
- EPS Growth
- TGL N/A
- PHIO N/A
- EPS
- TGL N/A
- PHIO N/A
- Revenue
- TGL $2,398,398.00
- PHIO N/A
- Revenue This Year
- TGL N/A
- PHIO N/A
- Revenue Next Year
- TGL N/A
- PHIO N/A
- P/E Ratio
- TGL N/A
- PHIO N/A
- Revenue Growth
- TGL N/A
- PHIO N/A
- 52 Week Low
- TGL $0.15
- PHIO $1.53
- 52 Week High
- TGL $8.69
- PHIO $10.35
- Technical
- Relative Strength Index (RSI)
- TGL 41.57
- PHIO 42.10
- Support Level
- TGL $0.16
- PHIO $1.64
- Resistance Level
- TGL $0.18
- PHIO $1.88
- Average True Range (ATR)
- TGL 0.02
- PHIO 0.13
- MACD
- TGL 0.00
- PHIO -0.02
- Stochastic Oscillator
- TGL 9.00
- PHIO 5.61
About TGL Treasure Global Inc.
Treasure Global Inc has created an online-to-offline e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retailers/merchant settings. Its product is an internet application branded ZCITY app, that targets consumers by providing personalized deals based on consumers' purchase history, location and preferences.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.